IN BRIEF: Hikma addresses gender imbalance with two new non-executives

Hikma Pharmaceuticals PLC - London-based pharmaceutical company - Appoints Laura Balan and ...

Alliance News 30 September, 2022 | 10:08AM
Email Form Facebook Twitter LinkedIn RSS

Hikma Pharmaceuticals PLC - London-based pharmaceutical company - Appoints Laura Balan and Victoria Hull as independent non-executive directors with effect from October 1 and November 1, respectively. Balan worked for 17 years at the Capital Group Co, where she covered European healthcare and pharmaceutical sectors. Hull is currently a non-executive director for IQE PLC, Alphaware IP Group PLC and Network International Holdings PLC. Previously she was chief legal officer & executive director at Invensys PLC, now Schneider Electric, from 2001 to 2014.

Says these two new appointments bring the level of female representation on the board to 40%, after shareholders voted against the re-election of Pat Butler at April's annual general meeting. After the AGM, female representation fell to 22% from 30%. Says the board has diversity targets following Hampton-Alexander Review and Parker Review.

Executive Chair & Chief Executive Said Darwazah comments: "Laura brings extensive knowledge of the global healthcare industry and an excellent track record of investing in a broad range of healthcare businesses. She is a strong strategic thinker who will add value to the board. Victoria brings broad experience across a range of businesses, having held executive and non-executive director roles. She has strong experience of the UK listed environment and brings extensive Merger & Aquisition experience to the board".

Current stock price: 1,368.00 pence

12-month change: down 44%

By Chris Dorrell; chrisdorrell@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
IQE PLC 28.90 GBX 3.21 -
Network International Holdings PLC 393.60 GBX 0.00 -
Alphawave IP Group PLC Ordinary Shares 125.80 GBX 6.79 -
Hikma Pharmaceuticals PLC 1,930.00 GBX 0.89 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures